Optomed Oyj
HEL:OPTOMED.HE
3.16 (EUR) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 15.04 | 15.1 | 14.66 | 14.85 | 13.011 | 14.977 | 14.463 | 6.899 | 6.609 |
| Cost of Revenue
| 5.374 | 4.857 | 5.448 | 5.102 | 4.213 | 5.286 | 4.954 | 3.118 | 2.99 |
| Gross Profit
| 9.666 | 10.243 | 9.212 | 9.748 | 8.798 | 9.691 | 9.509 | 3.781 | 3.619 |
| Gross Profit Ratio
| 0.643 | 0.678 | 0.628 | 0.656 | 0.676 | 0.647 | 0.657 | 0.548 | 0.548 |
| Reseach & Development Expenses
| 0.297 | 2.946 | 0.361 | 0.412 | 0.276 | 0.356 | 1.072 | 0.227 | 0.532 |
| General & Administrative Expenses
| 3.2 | 2.509 | 0.765 | 0.866 | 0.714 | 0.504 | 1.65 | 0.22 | 0.251 |
| Selling & Marketing Expenses
| 0.707 | 0.635 | 0.784 | 0.674 | 0.422 | 0.489 | 0.509 | 0.647 | 0.648 |
| SG&A
| 3.907 | 3.144 | 1.549 | 1.54 | 1.136 | 0.993 | 2.159 | 0.867 | 0.899 |
| Other Expenses
| 11.419 | 8.127 | 11.973 | 12.168 | 10.131 | 10.552 | 10.174 | 5.515 | 4.82 |
| Operating Expenses
| 15.623 | 14.217 | 13.883 | 14.12 | 11.543 | 11.901 | 10.174 | 6.609 | 6.251 |
| Operating Income
| -5.957 | -3.974 | -4.671 | -4.372 | -2.745 | -2.21 | -0.665 | -2.827 | -2.611 |
| Operating Income Ratio
| -0.396 | -0.263 | -0.319 | -0.294 | -0.211 | -0.148 | -0.046 | -0.41 | -0.395 |
| Total Other Income Expenses Net
| 0.441 | -0.545 | -0.88 | 0.045 | -0.341 | -0.356 | -0.555 | -0.063 | -0.151 |
| Income Before Tax
| -5.516 | -4.519 | -5.551 | -4.327 | -3.247 | -2.952 | -1.221 | -2.89 | -2.762 |
| Income Before Tax Ratio
| -0.367 | -0.299 | -0.379 | -0.291 | -0.25 | -0.197 | -0.084 | -0.419 | -0.418 |
| Income Tax Expense
| -0.066 | -0.078 | -0.079 | -0.078 | -0.07 | -0.077 | 0.048 | -0.003 | -0.003 |
| Net Income
| -5.45 | -4.441 | -5.472 | -4.249 | -3.177 | -2.875 | -1.268 | -2.887 | -2.758 |
| Net Income Ratio
| -0.362 | -0.294 | -0.373 | -0.286 | -0.244 | -0.192 | -0.088 | -0.418 | -0.417 |
| EPS
| -0.29 | -0.27 | -0.37 | -0.32 | -0.24 | -0.32 | -0.096 | -0.22 | -0.21 |
| EPS Diluted
| -0.29 | -0.27 | -0.37 | -0.32 | -0.24 | -0.32 | -0.096 | -0.22 | -0.21 |
| EBITDA
| -2.241 | -2.122 | -4.077 | -2.907 | -0.281 | -1.174 | 0.376 | -1.65 | -1.905 |
| EBITDA Ratio
| -0.149 | -0.141 | -0.278 | -0.196 | -0.022 | -0.078 | 0.026 | -0.239 | -0.288 |